Dermapharm Holding Stock
Dermapharm Holding SE
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Germany
- CEO
- Hans-Georg Feldmeier
- Employees
- 3,619
- Market cap
- €1.9 B
- IPO
- 12/04/2018
Dermapharm Holding SE is a healthcare company based in Grünwald, Germany. Founded in 1991, the company specializes in the off-patent branded pharmaceutical market, serving both German and international clients. The business operations are organized into three primary divisions: Branded Pharmaceuticals and Other…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Dermapharm Holding stock: price history
1D
-0.8%
1W
-1.4%
1M
-1.8%
6M
-18.1%
YTD
-3.8%
1Y
+15.9%
2Y
+15.4%
5Y
-55.2%
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~47% stronger price swings than usual
Ask the agents about Dermapharm Holding
Dermapharm Holding stock metrics
P/E
13.66
P/B
3.49
EV/EBITDA
8.43
RETURN ON EQUITY
4.3%
NET MARGIN
8.1%
DEBT/EQUITY
2.18
DIVIDEND YIELD
2.3%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
22.5%
FLOAT SHARES
11,143,115
AVG. DAILY VOLUME (30D)
25,888
Dividends
Comparable stocks
Frequently asked questions about Dermapharm Holding stock
What does Dermapharm Holding do?
Dermapharm Holding SE is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Germany.
The CEO is Hans-Georg Feldmeier, the company employs around 3,619 people.
The IPO was on 12/04/2018; the stock trades on XETRA under the ticker DMP.DE.
When does Dermapharm Holding report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 47% stronger than usual.
Does Dermapharm Holding pay a dividend?
Yes. The last dividend was €0.88 per share, ex-date 29/06/2026, paid on 01/07/2026.
The dividend yield is 2.3% (as of 30/06/2026).
Which stocks are comparable to Dermapharm Holding?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Dermapharm Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess Dermapharm Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.